What is the appropriate treatment for ascariasis in a pregnant patient?

Treatment for Ascariasis in Pregnancy

Pregnant women with ascariasis should be treated with pyrantel pamoate as the drug of choice, while albendazole and mebendazole are preferred for non-pregnant individuals but can be considered after the first trimester if needed. 1, 2

First-Line Treatment Approach

Drug Selection by Trimester

For pregnant patients, pyrantel pamoate is the recommended anthelminthic agent because albendazole and mebendazole are avoided during pregnancy, particularly in the first trimester, due to theoretical teratogenic concerns. 1, 2

• Pyrantel pamoate is the safest option throughout all trimesters of pregnancy and should be the first-line agent. 1, 2
• Albendazole (400 mg single dose) and mebendazole (500 mg single dose or 100 mg twice daily for 3 days) achieve cure rates exceeding 95% in non-pregnant populations but are typically reserved for use after the first trimester if pyrantel pamoate is unavailable or ineffective. 1, 3

Evidence on Safety in Pregnancy

Recent systematic review data supports that albendazole used during pregnancy demonstrates high cure rates (up to 90% for hookworm and Ascaris) with no increased risk of pregnancy loss, pre-term delivery, or serious adverse events compared to placebo. 3 However, the conservative approach remains to use pyrantel pamoate as first-line given its established safety profile. 1, 2

Special Clinical Scenarios

Biliary Ascariasis in Pregnancy

For pregnant patients presenting with biliary ascariasis (worms in the biliary tree), management should be stratified by severity: 4

• Conservative management with anthelminthic therapy is successful in approximately 60% of cases and should be attempted first. 4
• Endoscopic extraction may be required in non-responsive cases (successful in approximately 67% when needed), with lead shielding of the fetus and minimized fluoroscopic exposure to reduce radiation risk. 4
• Surgical intervention is reserved for failures of conservative and endoscopic management but carries risks of fetal wastage and premature labor (occurring in approximately 13% of surgical cases). 4

Complicated Ascariasis

For pregnant patients with intestinal obstruction or acute abdomen from ascariasis: 5

• Initial conservative management with nasogastric decompression, intravenous fluids, and anthelminthic therapy after stabilization is appropriate. 5
• Surgical exploration is reserved for complete obstruction or peritonitis. 5
• Ultrasonography is the preferred diagnostic and monitoring tool as it avoids radiation exposure to the fetus. 6, 4

Treatment Rationale and Monitoring

All pregnant patients with confirmed ascariasis warrant treatment, even if asymptomatic, to prevent complications from worm migration including biliary obstruction, pancreatitis, intestinal obstruction, and malnutrition. 1, 4

Key Clinical Considerations

• Gestational age matters: The majority of biliary ascariasis cases in pregnancy occur in the third trimester (approximately 67%), requiring heightened vigilance during this period. 4
• Ultrasonography is the diagnostic modality of choice in pregnant patients as it provides excellent visualization of worms in the biliary and intestinal systems without radiation exposure. 6, 4
• Routine deworming of women of childbearing age is recommended in endemic areas to prevent complications during pregnancy. 4

Common Pitfalls to Avoid

• Do not delay treatment in symptomatic pregnant patients due to concerns about medication safety—untreated ascariasis poses greater risks to both mother and fetus than appropriate anthelminthic therapy. 1, 4
• Do not assume asymptomatic infection is benign—worm migration can occur unpredictably, leading to serious complications. 1
• Avoid unnecessary surgical intervention in biliary ascariasis—the majority respond to conservative management, and surgery carries significant obstetric risks. 4